BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21112858)

  • 1. Multiple endocrine neoplasia 2: providing care for the family.
    Mahon SM; Waldman L
    Clin J Oncol Nurs; 2010 Dec; 14(6):803-6. PubMed ID: 21112858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia 1: providing care for the family.
    Mahon SM; Waldman L
    Clin J Oncol Nurs; 2010 Oct; 14(5):657-60. PubMed ID: 20880824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
    Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
    Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lump in the neck: 4 patients with a medullary thyroid carcinoma].
    Jansen M; Jansen-Schillhorn van Veen JM; Vroom TM; van Vroonhoven TJ; Lips CJ
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2234-41. PubMed ID: 11757248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer.
    Rubinstein WS
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):907-37. PubMed ID: 20816580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple endocrine neoplasia type 2a and 2b].
    Vestergaard P
    Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple endocrine neoplasia type IIa].
    Sćepanović D; Bajić N; Kadić R; Popović-Brkić V
    Srp Arh Celok Lek; 1994; 122(7-8):234-6. PubMed ID: 17974396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of multiple endocrine neoplasia Type 2.
    Bugalho MJ; Domingues R; Sobrinho L
    Expert Rev Mol Diagn; 2003 Nov; 3(6):769-79. PubMed ID: 14628904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phenotypic expression of a mutation in MEN 2A documented in a family in the western part of Sweden].
    Lindskog S; Ahlman H; Illerskog A; Nilsson O; Nilsson B; Tisell LE; Ysander L; Jansson S
    Lakartidningen; 2001 Aug; 98(35):3690-1, 3694-5. PubMed ID: 11577645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC.
    Chiefari E; Chiarella R; Crocetti U; Tardio B; Arturi F; Russo D; Trischitta V; Filetti S; Zingrillo M
    Horm Metab Res; 2001 Jan; 33(1):52-6. PubMed ID: 11280716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ret-protooncogene mutation, verified by molecular genetic methods, in a Hungarian MEN Type 2a family].
    Igaz P; Rácz K; Tóth M; Cserepes E; Esik O; Kiss R; Perner F; Gláz E; Tulassay Z
    Orv Hetil; 1999 Feb; 140(7):355-7. PubMed ID: 10091505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
    Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
    Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular aspects of multiple endocrine neoplasia.
    Wick MJ
    Clin Lab Med; 1997 Mar; 17(1):39-57. PubMed ID: 9138898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.